Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay

Sexually Transmitted Infections

Volumn 82, Issue 3, 2006, Pages 221-224

  Lavelle, Sara Jayne ^a,b   Jones, K E ^c   Mallinson, H ^d   Webb, A M C ^e  

^a Chlamydia Screening Office   (United Kingdom)

^b Liverpool and South Sefton Chlamydia Screening Programme   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e Abacus Clinics for Contraception and Reproductive Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; COLISTIN; GLUTAMINE; LINCOMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GONORRHEA; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MECHANICAL PROBE; MICROSCOPY; NEISSERIA GONORRHOEAE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SCREENING TEST; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ADULT; BACTERIOLOGICAL TECHNIQUES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE;

EID: 33745167327     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.017616     Document Type: Article

References (12)

1. Health Protection Agency. Gonorrhoea in England, Wales and Northern Ireland. CDR Weekly 2004;14(18).
2. Department of Health. Better prevention better services better sexual health: the national strategy for sexual health and HIV. London: DOH, 2001.
3. Lamontagne DS, Fenton KA, Randall S, et al. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sexually Trans Infect 2004;80:335-41.
4. Palmer HM, Mallinson H, Wood RL, et al. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J Clin Microbiol 2003;41:835-7.
5. Health Protection Agency. National standard method: chlamydial infection - testing by nucleic acid amplification tests VSOP. London: Health Protection Agency, 2005:37.
6. Society of Sexual Health Advisers. The manual for sexual health advisers. 2004 Available at, http://www.ssha.info/public/manual/ha_manual_2004_complete. pdf.
7. Jones K, Webb A, Mallinson H, et al. Outreach health adviser in a community clinic screening programme improves management of genital chlamydia infection. Sex Transm Infect 2002;78:101-5.
8. British Association for Sexual Health and HIV. Draft revised gonorrhoea guidelines. London: BASHH, 2004, Available at http://www.bashh.org/guidelines/ ceguidelines.htm.
9. Gaydos A, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for the muliplex detection of Chlamydia trachomatis and Neisseria gonorrhoea in women urine and endocervical swab specimens. J Clin Microbiol 2003;41:304-9.
10. Infectious Diseases Society of America. Positive predictive value of Gen-Probe APTIMA Combo 2 Testing for Neisseria gonorrhoeae in a population of women with low prevalence of N gonorrhoeae infection. Clin Infect Dis 2004;39:1387-90.
11. Fitzgerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS 1996;7:298-300.
12. GRASP. The Gonococcal Resistance to Antimicrobials Surveillance Programme-annual report 2004. London: Health Protection Agency, August 2005, Available at:http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/sti- gonorrhoea/publications/GRASP_2004_Annual_Report.pdf.